Papillary Renal Cell Carcinoma — Trials

Papillary Renal Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

32 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 14
Recruiting: 5
Ph III recruiting: 0
Growth YoY: —
Industry share: 21%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–10 of 10 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01767636	Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer	completed	Phase 2	38	Mayo ClinicOTHER	1	Mar 3, 2025	clinicaltrials
NCT02761057	Testing Cabozantinib, Crizotinib, Savolitinib and Sunitinib in Kidney Cancer Which Has Progressed	completed	Phase 2	152	National Cancer Institute (NCI)NIH	2	Jan 13, 2025	clinicaltrials